Clinical trials
Completed Non-alcoholic Fatty Liver Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
834 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 7 |
| 2004 | 4 |
| 2005 | 10 |
| 2006 | 9 |
| 2007 | 11 |
| 2008 | 18 |
| 2009 | 24 |
| 2010 | 20 |
| 2011 | 24 |
| 2012 | 24 |
| 2013 | 30 |
| 2014 | 28 |
| 2015 | 56 |
| 2016 | 51 |
| 2017 | 53 |
| 2018 | 64 |
| 2019 | 84 |
| 2020 | 67 |
| 2021 | 85 |
| 2022 | 59 |
| 2023 | 60 |
| 2024 | 29 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 834 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 17 |
| Pfizer | 15 |
| AstraZeneca | 11 |
| Gilead Sciences | 11 |
| Massachusetts General Hospital | 11 |
| Novo Nordisk A/S | 10 |
| University of Aarhus | 9 |
| University of California, San Diego | 8 |
| Bambino Gesù Hospital and Research Institute | 7 |
| Bristol-Myers Squibb | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 834 |
| Fatty Liver | 140 |
| Obesity | 113 |
| Diabetes Mellitus, Type 2 | 66 |
| Liver Diseases | 55 |
| Insulin Resistance | 52 |
| Liver Cirrhosis | 49 |
| Metabolic Syndrome | 45 |
| Diabetes Mellitus | 37 |
| Fibrosis | 36 |
Trials
Showing 76 to 100 of 834. Each trial links to its page on Pharma Observatory.
734 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.